Albemarle logged a 0.3% change during today's morning session, and is now trading at a price of $230.0 per share. ALB's trading volume is 168,381 compared to the stock's average volume of 2,299,505.
Albemarle trades -12.21% away from its average analyst target price of $261.98 per share. The 25 analysts following the stock have set target prices ranging from $155.0 to $360.0, and on average have given Albemarle a rating of buy.
If you are considering an investment in ALB, you'll want to know the following:
-
Albemarle's current price is 68.3% above its Graham number of $136.67, which implies that at its current valuation it does not offer a margin of safety
-
Based on its trailing earnings per share of 32.67, Albemarle has a trailing 12 month Price to Earnings (P/E) ratio of 7.0 while the S&P 500 average is 15.97
-
ALB has a forward P/E ratio of 10.5 based on its forward 12 month price to earnings (EPS) of $21.96 per share
-
The company has a price to earnings growth (PEG) ratio of -22.57 — a number near or below 1 signifying that Albemarle is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 2.93 compared to its sector average of 3.78
-
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide.
-
Based in Charlotte, the company has 7,400 full time employees and a market cap of $26.99 Billion. Albemarle currently returns an annual dividend yield of 0.7%.